Here, it was shown that the administration of 10 μM 1,8-cineol, which is successfully used as a drug component against human respiratory diseases [42], reduced LPS-induced IL-6 secretion in isolated human monocytes by 76 ± 10% [43]. Here, IL6 is linked to respiratory system disorder.